Início › Câncer Colorretal › Michigan › Detroit
Ensaios clínicos de Câncer Colorretal em Detroit, MI
26 estudos para Câncer Colorretal estão buscando participantes em locais em Detroit e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Recrutando
- Henry Ford, Detroit
Family Communications After Genetic Testing
RecrutandoVoluntários saudáveis bem-vindos
- Henry Ford Health Saint John Hospital, Detroit
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
RecrutandoFase 2
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecrutandoFase 3
- Henry Ford Hospital, Detroit
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecrutandoFase 3
- Henry Ford Hospital, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
RecrutandoFase 1/2
- GSK Investigational Site, Detroit
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecrutandoFase 3
- Henry Ford Hospital, Detroit
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecrutandoFase 3
- Clinical Study Site, Detroit
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Investigative Site #120, Detroit
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Henry Ford Health System, Detroit
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RecrutandoFase 2
- Karmanos Cancer Center, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Recrutando
- Karmanos Cancer Institute, Detroit
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecrutandoFase 1
- Karmanos Cancer Institute, Detroit
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RecrutandoFase 1
- Henry Ford Health System, Detroit
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
RecrutandoFase 3Voluntários saudáveis bem-vindos
- Henry Ford Health Saint John Hospital, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecrutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
RecrutandoFase 1
- Henry Ford Cancer-Detroit, Detroit
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RecrutandoFase 1
- Henry Ford Cancer Institute, Detroit
A Beta-only IL-2 ImmunoTherapY Study
RecrutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Ensaios de Câncer Colorretal em outras cidades
- Houston, TX102 estudos
- New York City, NY78 estudos
- Nashville, TN69 estudos
- Boston, MA63 estudos
- Los Angeles, CA59 estudos
- Arlington, VA52 estudos
- St. Louis, MO50 estudos
- San Antonio, TX46 estudos
- Philadelphia, PA44 estudos
- Grand Rapids, MI40 estudos
- Baldwin Park, CA37 estudos
- Chicago, IL34 estudos
Outros estudos em Detroit
- Câncer de Pulmão de Não Pequenas Células44 estudos
- Câncer de Mama33 estudos
- Câncer (todos os tipos)29 estudos
- Câncer de Ovário26 estudos
- Câncer Metastático24 estudos
- Câncer de Próstata22 estudos
- Câncer Endometrial21 estudos
- Câncer de Pulmão20 estudos
- Mieloma Múltiplo19 estudos
- Câncer de Estômago16 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço15 estudos
- Leucemia Mieloide Aguda14 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.